Business Description





We are a leading provider of manufactured vinyl coated fabrics. Our best-known
brand, Naugahyde, is the product of many improvements on a rubber-coated fabric
developed a century ago in Naugatuck, Connecticut. We design, manufacture and
market a wide selection of vinyl coated fabric products under a portfolio of
recognized brand names. We believe that our business has continued to be a
leading supplier in its marketplace because of our ability to provide
specialized materials with performance characteristics customized to the
end-user specifications, complemented by technical and customer support for the
use of our products in manufacturing.



Our vinyl coated fabric products have undergone considerable evolution and today
are distinguished by superior performance in a wide variety of applications as
alternatives to leather, cloth and other synthetic fabric coverings. Our
standard product lines consist of more than 525 SKUs with combinations of
colors, textures, patterns and other properties. Our products are differentiated
by unique protective top finishes and transfer print capabilities. Additional
process capabilities include embossing grains and patterns, and rotogravure
printing, which imparts five color character prints and non-registered prints,
lamination and panel cutting.



Our vinyl coated fabric products have various high-performance characteristics
and capabilities. They are durable, stain resistant, easily processed, more
cost-effective and better performing than traditional leather or fabric
coverings. Our products are frequently used in applications that require
rigorous performance characteristics such as automotive and non-automotive
transportation, certain indoor/outdoor furniture, commercial and hospitality
seating, health care facilities and athletic equipment. We manufacture materials
in a wide range of colors and textures. They can be hand or machine sewn,
laminated to an underlying structure, thermoformed to cover various substrates
or made into a variety of shapes for diverse end-uses. We are a long-established
supplier to the global automotive industry and manufacture products for interior
soft trim components from floor to headliner, which are produced to meet
specific component production requirements such as cut and sew, vacuum
forming/covering, compression molding, and high frequency welding. Some products
are supplied with micro perforations, which are necessary on most compression
molding processes. Materials can also be combined with polyurethane or
polypropylene foam laminated by either flame or hot melt adhesive for seating,
fascia and door applications.



Products are developed and marketed based upon the performance characteristics
required by end-users. For example, for recreational products used outdoors,
such as boats, personal watercraft, golf carts and snowmobiles, a product
designed primarily for water-based durability and weatherability is used. We
also manufacture a line of products called BeautyGard®, with water-based
topcoats that contain agents to protect against bacterial and fungal
micro-organisms and can withstand repeated cleaning, a necessity in the
restaurant and health care industries. These topcoats are environmentally
friendlier than solvent-based topcoats. The line is widely used in hospitals and
other health care facilities. Flame and smoke retardant vinyl coated fabrics are
used for a variety of commercial and institutional furniture applications,
including hospitals, restaurants and residential care centers and seats for
school buses, trains and aircraft.



We currently conduct our operations in manufacturing facilities that are located in Stoughton, Wisconsin and Earby, England.

Critical Accounting Policies and Estimates





The preparation of our consolidated financial statements and related disclosures
in conformity with U.S. generally accepted accounting principles ("U.S. GAAP")
requires management to make estimates and judgments that affect our reported
amounts of assets and liabilities, revenues and expenses, and related
disclosures of contingent assets and liabilities. On an on-going basis, we
evaluate our estimates and assumptions based upon historical experience and
various other factors and circumstances. We believe that our estimates and
assumptions are reasonable under the circumstances; however, actual results may
vary from these estimates and assumptions under different future circumstances.
For further discussion of our significant accounting policies, refer to Note 1 -
"Basis of Presentation and Summary of Significant Accounting Policies" to the
consolidated financial statements and "Management's Discussion and Analysis of
Financial Condition and Results of Operations - Critical Accounting Policies,
Judgments and Estimates" in our Annual Report on Form 10-K for the fiscal year
ended January 3, 2021.



 20


   Table of Contents




Overview:



We and our subsidiaries use a 52/53-week fiscal year ending on the Sunday
nearest to December 31. The current year ending January 2, 2022 is a 52-week
year whereas the prior year ended January 3, 2021 was a 53-week year. Our U.K.
subsidiaries use the calendar year end of December 31. The activity of the U.K.
subsidiaries that occurs on the days that do not coincide with our year-end is
not material. Both the three months ended July 4, 2021 and July 5, 2020 were
13-week periods while the six months ended July 4, 2021 was a 26-week period and
the six months ended July 5, 2020 was a 27-week period.



Our Earby, England operation's functional currency is the British Pound Sterling
("Pound Sterling") and has sales and purchases transactions that are denominated
in currencies other than the Pound Sterling, principally the Euro. Approximately
31% of our global revenues and 34% of our global raw material purchases are
derived from these Euro transactions.



The average year-to-date exchange rate for the Pound Sterling to the U.S. Dollar
was approximately 9.9% higher and the average exchange rate for the Euro to the
Pound Sterling was approximately 0.7% lower in 2021 compared to 2020. These
exchange rate changes had the effect of increasing net sales by approximately
$1,740,000 for the six months ended July 4, 2021. The overall currency effect on
our net income was a negative amount of approximately $24,000 for the six months
ended July 4, 2021.



Through the first quarter of 2021, demand for our products continued to improve
since the initial impact of COVID-19 on the global economy, which began for us
in the latter part of March 2020. However, sales in the second quarter of 2021
declined compared to the first quarter of 2021 as supply chain issues
experienced by the OEM's that use our automotive products lead to temporary
shutdowns of their production lines. As this supply chain problem exemplifies,
COVID-19 is a continually evolving situation and we cannot predict the long-term
impact the coronavirus will have on the economy or our business. The impact
could have a material adverse effect on our financial position, results of
operations and cash flows, which may require us to obtain additional financing.
We continue to pursue supplementary cash flow opportunities to provide further
liquidity, as described below.



In March 2021 and in April 2020, our U.S. operations received $2,000,000 and
$2,217,500, respectively, in funds from One Community Bank through the Paycheck
Protection Program ("PPP") administered by the U.S. Small Business
Administration ("SBA") under the Coronavirus Aid, Relief, and Economic Security
Act ("the CARES Act"). The $2,000,000 loan ("Second Draw PPP Loan") matures in
March 2026 and the $2,217,500 loan ("First Draw PPP Loan") matures in April
2022, and each bears an interest rate of 1.0%. The loans may be prepaid at any
time prior to maturity with no prepayment penalties.



All or a portion of the loans may be forgiven by the SBA for costs we incurred
for payroll, rent, utilities and all other allowable expenses during the 24-week
period that began March 1, 2021 for the Second Draw PPP Loan and April 13, 2020
for the First Draw PPP Loan. We used all proceeds from the loans to maintain
payroll and make payments for lease, utility and other allowable expenses. As a
result, management believes that we have met the PPP eligibility criteria for
forgiveness and has concluded that the loans represent, in substance, government
grants that are expected to be forgiven. As such, in accordance with
International Accounting Standards ("IAS") 20, "Accounting for Government Grants
and Disclosure of Government Assistance," we recognized the funding from the PPP
as grant income of $1,161,136 and $2,000,000 for the three and six months ended
July 4, 2021, respectively, and $2,183,676 for the three and six months ended
July 5, 2020. The remaining $33,824 of the First Draw PPP Loan was recognized as
grant income during the third quarter of 2020. These amounts are included as a
component of net other income in the consolidated statements of operations.

In June 2021 and August 2021, One Community Bank received payment from the SBA for forgiveness of our First and Second Draw PPP Loans, respectively.





 21


   Table of Contents




For the U.K. operations, during the second quarter of 2021 and 2020, we recorded
reimbursed costs of approximately $101,000 and $1,086,000, respectively, under
the Coronavirus Job Retention Scheme ("CJRS") set up by the U.K. government to
help employers pay the salaries of those employees who would otherwise have been
laid off during the coronavirus outbreak but under the CJRS were furloughed
instead. The much lower reimbursed costs for the second quarter of 2021
reflected that employees were furloughed significantly less than in the second
quarter of 2020. This program reimbursed us for up to 80% of the compensation
expense plus national insurance and certain benefits paid to the furloughed
employees, resulting in lower salary expense for us. While the employees were on
furlough, the compensation paid to them was limited to the amount reimbursed by
the CJRS. We recorded the reimbursed amounts as reductions to the associated
expenses.



Additionally for the U.K. operations, in June 2021 its bank lending facilities
with Lloyds Bank Commercial Finance Limited ("Lloyds") were refinanced with PNC
Business Credit ("PNC"). PNC provided us additional availability by expanding
our borrowing base to include eligible equipment. This transaction was accounted
for as a debt extinguishment per Accounting Standards Codification ("ASC") 470,
"Debt", under which the existing Lloyds debt was derecognized and the new PNC
debt was recorded at fair value. A loss of £46,813 ($64,911) was recognized on
this transaction and recorded in general and administrative expenses in the
consolidated statements of operations for the three and six months ended July 4,
2021. The loss was due to fees that were charged by Lloyds relating to the debt
extinguishment. Debt issuance costs of £247,114 ($339,712) were capitalized and
recorded in other long-term assets in the consolidated balance sheet as of July
4, 2021. These capitalized costs will be amortized over 36 months. See Notes 8
and 9 to the consolidated financial statements for further discussion.



Three Months Ended July 4, 2021 Compared to the Three Months Ended July 5, 2020





The following table sets forth, for the three months ended July 4, 2021 ("three
months 2021") and July 5, 2020 ("three months 2020"), certain operational data
including their respective percentage of net sales:



                                                                           Three Months Ended
                                                                                                                         %
                                                 July 4, 2021                 July 5, 2020              Change        Change

Net Sales                                  $ 17,749,235       100.0 %   $  7,216,371       100.0 %   $ 10,532,864        >100 %
Cost of Goods Sold                           15,927,442        89.7 %      7,506,718       104.0 %      8,420,724        >100 %
Gross Profit (Loss)                           1,821,793        10.3 %       (290,347 )      -4.0 %      2,112,140       <-100 %
Operating Expenses:
Selling                                         834,738         4.7 %        507,133         7.0 %        327,605        64.6 %
General and administrative                    1,439,488         8.1 %     

1,272,808        17.6 %        166,680        13.1 %
Research and development                        331,965         1.9 %        157,655         2.2 %        174,310        >100 %
Total Operating Expenses                      2,606,191        14.7 %      1,937,596        26.9 %        668,595        34.5 %
Operating Loss                                 (784,398 )      -4.4 %     (2,227,943 )     -30.9 %      1,443,545       -64.8 %
Interest expense                               (383,938 )      -2.2 %       (380,834 )      -5.3 %         (3,104 )       0.8 %
Funding from Paycheck Protection Program      1,161,136         6.5 %      2,183,676        30.3 %     (1,022,540 )     -46.8 %
Other expense                                   (40,945 )      -0.2 %        (80,281 )      -1.1 %         39,336       -49.0 %
Loss before Tax Benefit                         (48,145 )      -0.3 %       (505,382 )      -7.0 %        457,237       -90.5 %
Tax benefit                                    (244,184 )      -1.4 %       (240,193 )      -3.3 %         (3,991 )       1.7 %
Net Income (Loss)                               196,039         1.1 %       (265,189 )      -3.7 %        461,228       <-100 %
Preferred stock dividend                       (815,973 )      -4.6 %       (795,006 )     -11.0 %        (20,967 )       2.6 %
Net Loss Allocable to Common
Shareholders                               $   (619,934 )     -3.50 %   $ (1,060,195 )     -14.7 %   $    440,261       -41.5 %




 22


   Table of Contents




Revenue:



Total revenue for the three months 2021 increased $10,532,864 to $17,749,235
compared to $7,216,371 for the three months 2020. The much lower amount for the
three months 2020 reflected the negative effect of COVID-19, which impacted our
sales the most during the second quarter of 2020. The increase in revenue
included a favorable currency effect of approximately $743,000.



For the three months 2021 compared to the three months 2020, automotive sales
for both our U.S. operations and U.K. operations (excluding the currency
adjustment) grew more than 200% due to the negative effect of COVID-19 during
the second quarter of 2020. However, when comparing the second quarter of 2021
with the first quarter of 2021, automotive sales declined 27.7% primarily due to
a decline in sales for our U.K. operations, which was partially offset by a 1.7%
increase in automotive sales for our U.S. operations. As previously stated,
supply chain issues experienced by the OEM's that use our automotive products
lead to temporary shutdowns of their production lines, which negatively impacted
our sales.



Additionally for the three months 2021 compared to the three months 2020, sales
for the industrial sector increased 61.6% (58.8% before the currency effect)
mostly due to an increase in our U.S. operations (primarily in the contract
market) as well as in our U.K. operations. As discussed above, COVID-19 had a
negative effect on our operations during the second quarter of 2020. When
comparing the second quarter of 2021 with the first quarter of 2021, sales for
the industrial sector decreased 3.3% primarily due to a decline in the technical
market of our U.S. operations as the plant experienced difficulties in
fulfilling orders. Production changes have been implemented to resolve these
issues.



Gross Profit:



Total gross profit for the three months 2021 was $1,821,793 compared to
$(290,347) for the three months 2020. The gross profit percentage was 10.3% of
sales for the three months 2021 compared to -4.0% for the three months 2020.
Both the gross profit amount and percentage for the three months 2020 reflected
the negative impact of COVID-19. Manufacturing costs were reduced $83,000 and
$934,000 for the three months 2021 and 2020, respectively, from reimbursement
through the CJRS for salaries of furloughed employees. The increase in gross
profit included an unfavorable currency effect of approximately $19,000.



Total gross profit amount and percentage for the first quarter of 2021 were
$3,237,337 and 14.8%, respectively. When comparing the second quarter of 2021
with the first quarter of 2021, the decline in both the gross profit amount and
percentage were due to lower sales and higher costs of raw materials. To offset
raw material price increases, we increased prices during the first quarter of
2021 in several of our markets and announced an additional price increase
effective July 1, 2021.



Operating Expenses:



Selling expenses for the three months 2021 increased $327,605 or 64.6% to
$834,738 from $507,133 for the three months 2020. The lower amount for the three
months 2020 reflected reduced selling-related expenses due to lower sales
activity from the negative effect of COVID-19. Selling expenses were reduced
$7,000 and $56,000 for the three months 2021 and 2020, respectively, from
reimbursement through the CJRS for salaries of furloughed employees. The
increase in selling expenses was partially offset by a $50,000 favorable
currency effect. When comparing the second quarter of 2021 with the first
quarter of 2021, selling expenses decreased $63,974 or 7.1% primarily due to
lower employment costs.



General and administrative expenses for the three months 2021 increased $166,680
or 13.1% to $1,439,488 from $1,272,808 for the three months 2020. The increase
was primarily due to higher employment related costs and the loss associated
with the debt extinguishment. General and administrative expenses were reduced
$4,000 and $20,000 for the three months 2021 and 2020, respectively, from
reimbursement through the CJRS for salaries of furloughed employees. The
increase in general and administrative expenses was partially offset by a
$38,000 favorable currency effect.



Research and development expenses for the three months 2021 increased $174,310
or more than 100% to $331,965 from $157,655 for the three months 2020. The lower
amount for the three months 2020 reflected reduced activities including fewer
new trials due to the negative effect of COVID-19. Research and development
expenses were reduced $7,000 and $76,000 for the three months 2021 and 2020,
respectively, from reimbursement through the CJRS for salaries of furloughed
employees. The increase in research and development expenses was partially
offset by a $17,000 favorable currency effect. When comparing the second quarter
of 2021 with the first quarter of 2021, research and development expenses
increased $4,507 or 1.4% as higher costs of more activity in our U.S. operations
was mainly offset by lower costs of less activity in our U.K. operations.



 23


   Table of Contents




Operating Loss:



Operating loss for the three months 2021 was $784,398 compared to $2,227,943 for
the three months 2020. Operating losses in both periods were due to gross profit
being less than operating expenses with the much greater loss in the three
months 2020 reflecting the negative impact of COVID-19. The operating loss
percentage was -4.4% of sales for the three months 2021 compared to -30.9% for
the three months 2020. The $1,216,538 lower amount when comparing the second
quarter of 2021 operating loss with the first quarter of 2021 operating income
was due to the decline in gross profit, which was partially offset by the
decrease in operating expenses.



Interest Expense:



Interest expense for the three months 2021 increased less than 1.0% compared to
the three months 2020. When comparing the second quarter of 2021 with the first
quarter of 2021, interest expense decreased $19,808 or 4.9% due to debt
repayments.



Funding from Paycheck Protection Program:


Funding from the PPP of $1,161,136 (from the Second Draw PPP Loan) for the three
months 2021 and $2,183,676 (from the First Draw PPP Loan) for the three months
2020, were the proceeds from the PPP loans that we used during those periods for
allowable expenses under the PPP. As previously discussed, the First and Second
Draw PPP Loans were forgiven in June 2021 and August 2021, respectively.



Other Expense:



Other expense for the three months 2021 was $40,945 compared to $80,281 for the
three months 2020. Included in other expense are the currency gains and losses
recognized on foreign currency transactions and the change in the fair value of
financial assets and liabilities that are denominated in Euros as these
currencies fluctuated during the period.



Income Taxes:



We file income tax returns in the United States as a C-Corporation, and in
several state jurisdictions and in the United Kingdom. Our U.S. operating
subsidiary, Uniroyal, is a limited liability company (LLC) for federal and state
income tax purposes and as such, its income, losses, and credits pass through to
its members. We made the acquisition of Uniroyal through UEPH, a limited
liability company, which issued preferred ownership interests to the sellers
that provide for quarterly dividends. Uniroyal's taxable income is allocated
entirely to UEPH as its sole member and since it is a pass-through entity, this
income less the dividends paid to the sellers of Uniroyal is reported on our tax
return. The taxable income applicable to the dividends for the preferred
ownership interests is reported to the sellers who report it on their respective
individual tax returns.



We do not have a history of repatriating a significant portion of our foreign
cash. However, if we decided to repatriate these foreign amounts to fund U.S.
operations, we would not be required to pay any additional U.S. tax related to
these amounts since we previously recorded a one-time transition tax on deemed
repatriation of deferred foreign income.



The tax benefit for the three months 2021 was $244,184 compared to $240,193 for
the three months 2020. The tax benefit for the three months 2021 was
attributable almost equally to the results of the U.S. and U.K. operations while
the tax benefit for the three months 2020 was principally attributable to the
results of the U.S. operations.



Preferred Stock Dividend:



Pursuant to the terms of their acquisitions, the issuance of preferred ownership
units/stock of UEP Holdings, LLC and UGEL were issued to the sellers. These
preferred units have carried quarterly dividend requirements on a total value of
$55,000,000 at rates ranging from 5.0% to 8.0%. The dividend rate on the Series
B UEP Holdings preferred units which started at 5.5% increased by 0.5% on the
anniversary of the issuance and is now at the maximum of 8.0%. Quarterly
dividend payments have been deferred each quarter beginning with the dividends
that were accrued for the three months ended December 29, 2019 through the
dividends that were accrued for the three months ended July 4, 2021 in order to
preserve cash and provide additional liquidity. As of July 4, 2021 and January
3, 2021, accrued dividends of $5,596,391 and $4,019,905, respectively, were
included in accrued expenses and other liabilities in the accompanying
consolidated balance sheets.



 24


   Table of Contents




Six Months Ended July 4, 2021 Compared to the Six Months Ended July 5, 2020

The following table sets forth, for the six months ended July 4, 2021 ("six months 2021") and July 5, 2020 ("six months 2020"), certain operational data including their respective percentage of net sales:





                                                                            Six Months Ended
                                                                                                                         %
                                                 July 4, 2021                 July 5, 2020              Change        Change

Net Sales                                  $ 39,645,236       100.0 %   $ 28,356,495       100.0 %   $ 11,288,741        39.8 %
Cost of Goods Sold                           34,586,106        87.2 %     24,816,260        87.5 %      9,769,846        39.4 %
Gross Profit                                  5,059,130        12.8 %      3,540,235        12.5 %      1,518,895        42.9 %
Operating Expenses:
Selling                                       1,733,450         4.4 %     

1,499,580 5.3 % 233,870 15.6 % General and administrative

                    3,018,515         7.6 %      2,876,525        10.1 %        141,990         4.9 %
Research and development                        659,423         1.7 %        506,057         1.8 %        153,366        30.3 %
Total Operating Expenses                      5,411,388        13.6 %      4,882,162        17.2 %        529,226        10.8 %
Operating Loss                                 (352,258 )      -0.9 %     (1,341,927 )      -4.7 %        989,669       -73.7 %
Interest expense                               (787,684 )      -2.0 %      

(848,317 ) -3.0 % 60,633 -7.1 % Funding from Paycheck Protection Program 2,000,000 5.0 % 2,183,676 7.7 % (183,676 ) -8.4 % Other income (expense)

                          165,359         0.4 %       

(271,170 ) -1.0 % 436,529 <-100 % Income (Loss) before Tax Benefit

              1,025,417         2.6 %       (277,738 )      -1.0 %      1,303,155       <-100 %
Tax benefit                                    (206,623 )      -0.5 %       (292,823 )      -1.0 %         86,200       -29.4 %
Net Income                                    1,232,040         3.1 %         15,085         0.1 %      1,216,955        >100 %
Preferred stock dividend                     (1,632,387 )      -4.1 %     (1,587,841 )      -5.6 %        (44,546 )       2.8 %
Net Loss Allocable to Common
Shareholders                               $   (400,347 )      -1.0 %   $ (1,572,756 )      -5.5 %   $  1,172,409       -74.5 %






Revenue:



Total revenue for the six months 2021 increased $11,288,741 or 39.8% to
$39,645,236 from $28,356,495 for the six months 2020. The lower amount for the
six months 2020 reflected the negative effect of COVID-19, which primarily
occurred during the second quarter of 2020. The increase in revenue included a
favorable currency effect of approximately $1,740,000.



For the six months 2021 compared to the six months 2020, automotive sales for
our U.K. operations increased 46.8% (excluding the currency adjustment) and
automotive sales for our U.S. operations increased 34.1% due to the negative
effect of COVID-19 primarily during the second quarter of 2020. However, the
year-to-date growth was negatively impacted by supply chain issues experienced
by the OEM's that use our automotive products, which lead to temporary shutdowns
of their production lines during the second quarter of 2021.



 25


   Table of Contents




Additionally, sales for the industrial sector increased 23.4% (21.6% before the
currency effect) mostly due to an increase in our U.S. operations (primarily in
the contract market) as well as in our U.K. operations. As discussed above,
COVID-19 had a negative effect on our operations primarily during the second
quarter of 2020. However, the year-to-date growth was negatively impacted by
difficulties in fulfilling orders at the plant of our U.S. operations during the
second quarter of 2021. Production changes have been implemented to resolve

these issues.



Gross Profit:



Total gross profit for the six months 2021 increased $1,518,895 or 42.9% to
$5,059,130 from $3,540,235 for the six months 2020. The gross profit percentage
was 12.8% of sales for the six months 2021 compared to 12.5% for the six months
2020. Both the gross profit amount and percentage for the six months 2020
reflected the negative impact of COVID-19. The year-to- date increase in the
gross profit and percentage for the six months 2021 was negatively impacted by
supply chain and fulfillment issues, as discussed above, as well as higher costs
of raw materials. To offset raw material price increases, we increased prices
during the first quarter of 2021 in several of our markets and announced an
additional price increase effective July 1, 2021. Manufacturing costs were
reduced $83,000 and $934,000 for the six months 2021 and 2020, respectively,
from reimbursement through the CJRS for salaries of furloughed employees. The
increase in gross profit included a favorable currency effect of approximately
$166,000.



Operating Expenses:



Selling expenses for the six months 2021 increased $233,870 or 15.6% to
$1,733,450 from $1,499,580 for the six months 2020. The lower amount for the six
months 2020 reflected reduced selling-related expenses due to lower sales
activity from the negative effect of COVID-19 primarily during the second
quarter of 2020. Selling expenses were reduced $7,000 and $56,000 for the six
months 2021 and 2020, respectively, from reimbursement through the CJRS for
salaries of furloughed employees. The increase in selling expenses was partially
offset by a $94,000 favorable currency effect.



General and administrative expenses for the six months 2021 increased $141,990
or 4.9% to $3,018,515 from $2,876,525 for the six months 2020. The increase was
primarily due to higher employment related costs and the loss associated with
the debt extinguishment. General and administrative expenses were reduced $4,000
and $20,000 for the six months 2021 and 2020, respectively, from reimbursement
through the CJRS for salaries of furloughed employees. The increase in general
and administrative expenses was partially offset by a favorable currency effect
of $68,000.



Research and development expenses for the six months 2021 increased $153,366 or
30.3% to $659,423 from $506,057 for the six months 2020. The lower amount for
the six months 2020 reflected reduced activities including fewer new trials due
to the negative effect of COVID-19 primarily during the second quarter of 2020.
Research and development expenses were reduced $7,000 and $76,000 for the six
months 2021 and 2020, respectively, from reimbursement through the CJRS for
salaries of furloughed employees. The increase in research and development
expenses was partially offset by a $31,000 favorable currency effect.



Operating Loss:



Operating loss for the six months 2021 was $352,258 compared to $1,341,927 for
the six months 2020. Operating losses in both periods were due to gross profit
being less than operating expenses with the much greater loss in the six months
2020 reflecting the negative impact of COVID-19 primarily during the second
quarter of 2020. The operating loss percentage was -0.9% of sales for the six
months 2021 compared to -4.7% for the six months 2020.



Interest Expense:



Interest expense for the six months 2021 decreased $60,633 or 7.1% to $787,684
from $848,317 for the six months 2020. The decrease was primarily due to lower
interest rates on LIBOR and prime during the six months 2021 and debt
repayments.



Funding from Paycheck Protection Program:


Funding from the PPP of $2,000,000 (from the Second Draw PPP Loan) for the six
months 2021 and $2,183,676 (from the First Draw PPP Loan) for the six months
2020, were the proceeds from the PPP loans that we used during those periods for
allowable expenses under the PPP. As previously discussed, the First and Second
Draw PPP Loans were forgiven in June 2021 and August 2021, respectively.



 26


   Table of Contents




Other Income (Expense):



Other income for the six months 2021 was $165,359 compared to other expense of
$(271,170) for the six months 2020. Included in other income (expense) are the
currency gains and losses recognized on foreign currency transactions and the
change in the fair value of financial assets and liabilities that are
denominated in Euros as these currencies fluctuated during the period.



Income Taxes:



We file income tax returns in the United States as a C-Corporation, and in
several state jurisdictions and in the United Kingdom. Our U.S. operating
subsidiary, Uniroyal, is a limited liability company (LLC) for federal and state
income tax purposes and as such, its income, losses, and credits pass through to
its members. We made the acquisition of Uniroyal through UEPH, a limited
liability company, which issued preferred ownership interests to the sellers
that provide for quarterly dividends. Uniroyal's taxable income is allocated
entirely to UEPH as its sole member and since it is a pass-through entity, this
income less the dividends paid to the sellers of Uniroyal is reported on our tax
return. The taxable income applicable to the dividends for the preferred
ownership interests is reported to the sellers who report it on their respective
individual tax returns.



We do not have a history of repatriating a significant portion of our foreign
cash. However, if we decided to repatriate these foreign amounts to fund U.S.
operations, we would not be required to pay any additional U.S. tax related to
these amounts since we previously recorded a one-time transition tax on deemed
repatriation of deferred foreign income.



The tax benefit for the six months 2021 was $206,623 compared to $292,823 for the six months 2020. The tax benefit for the six months 2021 and 2020 was principally attributable to the results of the U.S. operations.





Preferred Stock Dividend:



Pursuant to the terms of their acquisitions, the issuance of preferred ownership
units/stock of UEP Holdings, LLC and UGEL were issued to the sellers. These
preferred units have carried quarterly dividend requirements on a total value of
$55,000,000 at rates ranging from 5.0% to 8.0%. The dividend rate on the Series
B UEP Holdings preferred units which started at 5.5% increased by 0.5% on the
anniversary of the issuance and is now at the maximum of 8.0%. Quarterly
dividend payments have been deferred each quarter beginning with the dividends
that were accrued for the three months ended December 29, 2019 through the
dividends that were accrued for the three months ended July 4, 2021 in order to
preserve cash and provide additional liquidity. As of July 4, 2021 and January
3, 2021, accrued dividends of $5,596,391 and $4,019,905, respectively, were
included in accrued expenses and other liabilities in the accompanying
consolidated balance sheets.



Liquidity and Sources of Capital





Cash, as it is needed, is provided by using our lines of credit. These lines
provide for a total borrowing commitment in excess of $30,000,000 subject to the
underlying borrowing base specified in the agreements. Of the total outstanding
borrowings of $17,397,346 at July 4, 2021, for the U.S. operations, $6.0 million
of the lines bears interest at the Eurodollar rate plus 2.25% and $4.5 million
bears interest at the Wells Fargo Capital Finance, LLC's prime rate (3.25% at
July 4, 2021), and for the U.K. operations, $6.9 million bears interest at the
Bank of England Base Rate plus 2.25%-3.00%. The lines provided additional
availability of approximately $2.0 million and, combined with UEP's and UGL's
total cash balances, liquidity was approximately $3.1 million at July 4, 2021.
We plan to use this availability and cash provided by operating activities to
finance our cash needs for the remaining months of fiscal 2021 and future
periods. The balances due under the lines of credit are recorded as current
liabilities on the consolidated balance sheets.



Impacting the liquidity discussion above, in March of 2021, our U.S. operations
received $2.0 million in funds through the Paycheck Protection Program
administered by the United States Small Business Administration. As previously
stated, this debt was forgiven in August 2021.



The ratio of current assets to current liabilities, including the amount due under our lines of credit, was 0.88 at July 4, 2021 and 0.89 at January 3, 2021.





 27


   Table of Contents




Cash balances decreased $566,071 before the effects of currency translation of
$24,968, to $1,115,779 at July 4, 2021 from $1,656,882 at January 3, 2021. Of
the above noted amounts, $94,667 and $1,621,692 were held outside the U.S. by
our foreign subsidiaries as of July 4, 2021 and January 3, 2021, respectively.



Cash used in operations was $1,415,663 for the six months 2021 compared to cash
provided by operations of $5,752,683 for the six months 2020. For the six months
2021, cash used in operations was primarily due to changes in working capital of
$(1,850,065), adjustments for non-cash items of $(780,125) and changes in other
assets and liabilities of $(17,513) offset by net income of $1,232,040. For the
six months 2020, cash provided by operations was primarily due to changes in
working capital of $7,017,139 and net income of $15,085 offset by adjustments
for non-cash items of $(1,255,414) and changes in other assets and liabilities
of $(24,127).



Cash used in investing activities was $464,073 for the six months 2021 compared
to $919,610 for the six months 2020. During 2021 and 2020, cash used in
investing activities was principally for purchases of machinery and equipment at
our manufacturing locations and payments made for company-owned key man life
insurance premiums.



For the six months 2021, cash provided by financing activities was $1,313,665
compared to cash used in financing activities of $4,085,134 for the six months
2020. Impacting cash flows from financing activities for the six months 2021 and
2020 were proceeds from issuance of long-term debt of $2,000,000 and $2,217,500,
respectively, through the Paycheck Protection Program. Also impacting cash flows
from financing activities for the six months 2021 and 2020 were net advances on
lines of credit of $376,351 and net payments of $4,685,592, respectively. The
changes in the lines of credit reflect the funding of working capital. Payments
of $694,065 and $856,442 were also made during the six months 2021 and 2020,
respectively, on long-term debt (excluding debt extinguishment) and finance
lease liabilities. For the six months 2021, payments were $1,489,800 and
proceeds were $2,333,683 relating to the extinguishment of existing long-term
debt and recognition of new long-term debt, respectively, while payments were
$7,395,719 and proceeds were $6,579,847 relating to the extinguishment of an
existing line of credit and recognition of a new line of credit, respectively.
Also included for the six months 2021 were payments for capitalized debt
issuance costs of $342,653. For the six months 2020, payments of $575,000 were
made on subordinated secured promissory notes to our majority shareholder.
Proceeds of $200,000 were received from a short-term advance from our majority
shareholder during the first six months of 2020 which was repaid in the same
period.



Our credit agreements contain customary affirmative and negative covenants. We
were in compliance with our debt covenants as of July 4, 2021 and through the
date of filing of this report.



We currently have several on-going capital projects that are important to our
long-term strategic goals. Machinery and equipment will also be added as needed
to increase capacity or enhance operating efficiencies in our manufacturing
plants. We will use a combination of financing arrangements to provide the
necessary capital. We believe that our existing resources, including cash on
hand and our credit facilities, together with cash generated from operations and
additional bank borrowings, will be sufficient to fund our cash flow
requirements through at least the next twelve months. However, there can be no
assurance that additional financing will be available on favorable terms, if at
all.


We have no off balance sheet arrangements.





 28


   Table of Contents

© Edgar Online, source Glimpses